Institute Presentation 4.2
Targeted Treatment for Neurodevelopmental Disorders: Reversing Underlying Neurobiological Deficits in Fragile X Syndrome

Wednesday, October 28, 2015 7:30 AM
Dejan B. Budimirovic, MD, Medical Director, Fragile X Clinic, KKI, JHMI, Clinical Trials Center, Kennedy Krieger Institute, The Johns Hopkins Medical Institutions, Baltimore, MD
See more of: The Developmental Neuropsychiatry of Intellectual Developmental Disability: Advances in Classification, Diagnosis, and Treatment
See more of: Institute
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.